Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
493,037,296
-
Share change
-
-6,039,908
-
Total reported value
-
$3,705,698,809
-
Put/Call ratio
-
77%
-
Price per share
-
$7.52
-
Number of holders
-
414
-
Value change
-
-$46,278,063
-
Number of buys
-
174
-
Number of sells
-
145
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2022
As of 30 Jun 2022,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
414 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
493,037,296 shares.
The largest 10 holders included
Capital Research Global Investors, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., MENORA MIVTACHIM HOLDINGS LTD., Migdal Insurance & Financial Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, Phoenix Holdings Ltd., STATE STREET CORP, Harel Insurance Investments & Financial Services Ltd., and Capital International Investors.
This page lists
417
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.